Form 4: DENTSPLY SIRONA Director Acquires RSU Dividends

DENTSPLY SIRONA Inc. Director Clyde Hosein acquired 355.0455 common stock equivalent units through RSU dividends, increasing his direct beneficial ownership to 41,252.522 shares.

Summary

• Clyde Hosein, a Director of DENTSPLY SIRONA Inc. (XRAY), acquired 355.0455 shares of Common Stock on January 9, 2026.
• This acquisition represents dividends on previously awarded restricted stock units (RSUs), granted in the form of additional RSUs.
• The acquired RSU dividends are subject to the same vesting terms as the underlying awards and vest simultaneously.
• Each RSU converts to common stock on a 1:1 basis.
• Following this transaction, Clyde Hosein directly beneficially owns 41,252.522 shares of Common Stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. This is a routine, expected transaction related to director compensation (RSU dividends) and not an open market purchase or sale. It indicates continued equity participation by a director, which is generally viewed as a positive for alignment, but does not signal new strategic or financial developments.

Positives

• A director's acquisition of additional equity, even through RSU dividends, generally indicates continued alignment of interests with shareholders.
• The transaction was conducted under a Rule 10b5-1 plan, demonstrating a pre-arranged, compliant approach to insider transactions.

Future Outlook

Not applicable, as this Form 4 filing pertains to an individual insider transaction and does not contain company-specific forward-looking statements or guidance.

Industry Context

This is a routine insider transaction, common across publicly traded companies where directors and executives receive equity compensation, including dividends on restricted stock units. Such transactions are typically part of pre-established compensation plans and are not indicative of broader industry trends or competitive shifts.

Comparison to Industry Standards

• The acquisition of shares through RSU dividends is a standard component of equity compensation for directors and executives in many public companies, aligning their interests with long-term shareholder value.
• The use of a Rule 10b5-1 plan for such transactions is a common corporate governance practice, providing an affirmative defense against insider trading allegations by establishing a pre-arranged trading schedule.

Corporate Governance

Stakeholder Impact

• Shareholders: The acquisition of additional equity by a director, even through RSU dividends, can be viewed positively as it reinforces management's alignment with shareholder interests.

Key Dates

Recommendation

This Form 4 reports a routine acquisition of shares by a director through restricted stock unit (RSU) dividends, which is a standard part of compensation. It does not provide new information that would significantly alter the investment thesis or warrant a change in recommendation. Investors should continue to evaluate DENTSPLY SIRONA based on its fundamental financial performance, strategic initiatives, and broader market conditions.

Keywords

DENTSPLY SIRONA, XRAY, Form 4, Insider Transaction, RSU, Restricted Stock Units, Director, Stock Acquisition, Beneficial Ownership, Rule 10b5-1